Neurorehabilitation devices market is estimated to be over US$ 1.5 Billion in 2019. It is anticipated to grow at ~15% CAGR from 2019 to 2030.
In case of neurological disorders, there are often physical and mental limitations which require individualized concepts to enable safe and effective implementation of the training and rehabilitation programs. Wide scale adoption of robot-assisted devices is observed in neurorehabilitation for supporting and controlling the required movements to restore normal functionality of body. The latest development in robotics includes wearable robots adapted to the human body, which helps in precise adapted support for physical movements. Moreover, increasing prevalence of neurological disorder is contributing in the market growth. For instance, according to Alzheimer’s Association, by 2050 the number of people age 65 and older with Alzheimer’s dementia will grow to a projected 13.8 million. However, the lack of technicality and ease of usage of these devices along with shortage of personalized home care equipped with neurorehabilitation devices hinders the growth of neurorehabilitation devices market to a certain extent during the forecast period.
Major Key Players of the Neurorehabilitation Devices Market are:
Medtronic, Ectron, Abbott, Boston Scientific Corporation, Ekso Bionics, MagVenture, Inc., Hocoma, Neuro Style, Neofect, and Tyromotion GmbH among others.
No comments:
Post a Comment